RE:RE:))))Shroom Doom((((
I fully agree. People will wake up to it soon enough. Lot of pennies trading .15 and up cant even say the are having any real sort of revenue but are trading on hype and blue sky potential. 3.5 million is it in accretive value is not a joke. Many pennies dont generate that. I had talked about this several times in the past. What is key for this company is for all the overheads to remain low continue to use the online approach effectively cut advertising marketing costs and keep that invested for the distribution channels while making sure the manufacturing costs remain as level as possible. This is all about branding brand loyalty and creating a presence where you have your clients and earn a good revenue from supplying products to those you sell to. Companies in this position are no less than .15 and many in fact .20 to .30 but look all this will be shown in time and as more clout and credibility continues to be built the share value should keep moving up if not at the right value at least a little more reflective of it. This looks stable around .11 which is a pretty good looking entry point/add point but that doesnt mean you wont see people trying to cut this down as they have been doing trying to get cheap shares this is already not priced where it should actually be trading. I went through this with another company that is above $1.00 now I am not saying that for this one just yet as the other company was dealing with scientifically backed medical companies doing the analytics for them in terms of their research I talked about all this in a past post. This company either owns as wholly subsidiary or percentage stake in companies that run metrics. This company may be able to use those metrics to analyze group and make metrics easier for companies doing research. The other company shg also has telehealth and existing physical clinics that medically treat people with cbd. Additionally it has a key long term backer Meridia Capital so that is why for a large part of getting to where it is...they reached EBITDA positive which is moving towards net or overall profitability for all those reasons it trades above a buck. This really should be .15 plus but look all the pricing and what not will continue to move towards a fairer price over time but at this point yeah undervalued.